EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

IVIM Technology, Inc (460470) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of IVIM Technology, Inc KRW 1,197, price KRW 2,600, upside -54.0%, quality 34 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · KR

IT Thin data Sep 24, 2026

IVIM Technology, Inc

460470 · KQ

Weakest SetupStrongly overvalued and low quality.

!Fair value 1,197 KRW · Strongly overvalued (−54%)
!Quality 34/100
!Expensive Growth (revenue 3y +48.4 %/yr)
!Loss-making · -87.3% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (1/7)
!Narrow moat 6/100
!Evidence only low, so the estimate is less certain
Watch IVIM Technology, Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

13,360 KRW 2,530 KRW Fair Value 1,197 KRW Aug 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

26‑month range 2,530 KRW – 13,360 KRW · fair‑value band 789.71 KRW – 1,496 KRW · the 2,600 KRW price screens above the 1,197 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow IVIM Technology in your weekly email

Every Wednesday you see whether IVIM Technology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

IVIM Technology, Inc. develops intravital microscopy (IVM) platform.

Show more

IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products. The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications. The company was founded in 2017 and is based in Daejeon, South Korea.

Stock analysis

IVIM Technology, Inc (460470) currently trades at 2,600 KRW, while our model-based Fair Value estimate is 1,197 KRW, implying the stock looks roughly 117.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: 789.71 KRW (bear) to 1,496 KRW (bull), the price of 2,600 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

IVIM Technology, Inc reported revenue of 4.4B KRW in FY2025 versus 527M KRW in FY2021, a compound +69.8%/yr. Reported net income was −3.8B KRW in FY2025.

Key figures

Market cap 42.5B KRW (≈ $31.2M) · P/S ratio 9.87 · Net margin −86.9% · Return on equity −13.4% · Return on assets (EBIT) −19.9% · Operating margin −1,897% · Revenue (TTM) 4.3B KRW · Revenue growth (YoY) −48.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 45% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −54%, 460470 screens richer than that median.

Fair Value models

Bear 789.71 KRW Fair Value 1,197 KRW Bull 1,496 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) 913.98 KRW 1,225 KRW 1,828 KRW 54
All 1 models by family
Asset-Based
NCAV (Graham) 913.98 KRW 1,225 KRW 1,828 KRW 54

Open the full fair value analysis →

Notify me when 460470 reaches fair value

Put 460470 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 34/100

Of which business quality 39 · Market factors (momentum, volatility) 12

Profitability 2
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 14
Earnings quality: real cash, not paper profit
Fin. Strength 83
Balance sheet, leverage, solvency risk
Investment 9
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 20
Price trend over the last 3–12 months (market factor)
52W Momentum 10
Distance to the 52-week high (market factor)
Net Issuance 80
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+22.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+48.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−504.5% (2021) → −94.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

460470 screens 117% overvalued. Compare with Abbott Laboratories, →

Compare IVIM Technology, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 39 · Bottom 25%
Fair Value upside −54% · Below median
Profitability
Return on assets −8% · Below median
Net margin (TTM) −87% · Bottom 25%
Growth and dividend
Revenue growth −49% · Bottom 25%
Balance sheet
Debt / equity 0.03× · Below median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 10
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)0 · sector 7
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 40

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $101.07 $74.79 −26%
Stryker Corporation SYK $273.40 $300.74 +10%
Medtronic plc MDT $89.30 $65.57 −27%
Boston Scientific Corporation BSX $44.62 $49.08 +10%
Edwards Lifesciences Corporation EW $86.82 $82.04 −6%
Siemens Healthineers AG SHL €37.21 €35.22 −5%
DexCom, Inc DXCM $87.73 $96.50 +10%
GE HealthCare Technologies Inc GEHC $66.27 $69.62 +5%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥156.68 ¥172.35 +10%
Koninklijke Philips N.V PHIA €21.85 €15.32 −30%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

IVIM Technology, Inc · Fair Value
1,197 KRW −117%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "IVIM Technology, Inc Fair Value". https://www.fairvalue-calculator.com/stock/460470

Frequently asked questions

Is IVIM Technology, Inc (460470) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 1,197 KRW versus a price of 2,600 KRW, about −54% upside (overvalued).
What is the fair value of 460470?
Our model-based fair value for IVIM Technology, Inc is 1,197 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,600 KRW.
What is the quality score of 460470?
IVIM Technology, Inc has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for IVIM Technology, Inc (460470)?
Our model-based price target is the fair value of 1,197 KRW (as of Sep 24, 2026) from 1 valuation models. Cautious scenario 789.71 KRW, optimistic scenario 1,496 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the IVIM Technology, Inc stock forecast for 2026?
Our models put fair value at 1,197 KRW, about −54% upside versus a price of 2,600 KRW (overvalued). Cautious scenario 789.71 KRW, optimistic scenario 1,496 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of IVIM Technology, Inc (460470)?
IVIM Technology, Inc reported trailing-twelve-month revenue of about 4.3B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of IVIM Technology, Inc (460470)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For IVIM Technology, Inc it is 1,197 KRW per share (as of Sep 24, 2026), against a price of 2,600 KRW. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is IVIM Technology, Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 460470 trades above its calculated fair value: price 2,600 KRW, fair value 1,197 KRW, a gap of about −54% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 460470?
No. The price is what the market pays today (2,600 KRW); the fair value is what the company's own numbers justify (1,197 KRW). For IVIM Technology, Inc the two are 1,403 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is IVIM Technology, Inc worth?
The market values IVIM Technology, Inc at about 42.5B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 2,600 KRW; our models calculate a fair value of 1,197 KRW per share.
What do the bullish and bearish scenarios say about 460470?
Our models span a range for IVIM Technology, Inc: cautious scenario 789.71 KRW, base 1,197 KRW, optimistic 1,496 KRW per share (as of Sep 24, 2026, price 2,600 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of IVIM Technology, Inc (460470)?
Balance-sheet figures for IVIM Technology, Inc (as of Sep 24, 2026): return on equity −13.4%, debt of 0.03 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is 460470 from its 52-week high?
IVIM Technology, Inc trades at 2,600 KRW, about 45% below its 52-week high of 4,745 KRW and 3% above the low of 2,530 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 1,197 KRW is for.
Which stocks are comparable to IVIM Technology, Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is IVIM Technology, Inc stock attractive at the current price?
The data as of Sep 24, 2026: price 2,600 KRW, calculated fair value 1,197 KRW (−54%), Quality Score 34/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 460470 calculated?
We run IVIM Technology, Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1,197 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. IVIM Technology, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of IVIM Technology, Inc (460470)?
The closing price on Sep 23, 2026 was 2,600 KRW. Our model-based fair value is 1,197 KRW, about −54% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with IVIM Technology, Inc right now?
The price sits above even our optimistic bull case (1,496 KRW). The favourable scenario is already priced in. Weak quality (34/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (789.71 KRW to 1,496 KRW) leaves room in how you read the outcome.

Key figures of IVIM Technology, Inc

How large is the market capitalisation of IVIM Technology, Inc (460470)?
The market capitalisation of IVIM Technology, Inc is 42.5B KRW (≈ $31.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of IVIM Technology, Inc (460470)?
The price-to-sales ratio of IVIM Technology, Inc is 9.87 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of IVIM Technology, Inc (460470)?
The net margin of IVIM Technology, Inc is −86.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of IVIM Technology, Inc (460470)?
The return on equity (ROE) of IVIM Technology, Inc is −13.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of IVIM Technology, Inc (460470)?
On an EBIT basis the return on assets of IVIM Technology, Inc is −19.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of IVIM Technology, Inc (460470)?
The operating margin of IVIM Technology, Inc is −1,897% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at IVIM Technology, Inc (460470)?
Revenue at IVIM Technology, Inc is growing −48.9% versus a year earlier (3y avg +48.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does IVIM Technology, Inc (460470) generate?
The free cash flow of IVIM Technology, Inc is −6.7B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does IVIM Technology, Inc (460470) carry?
The net debt of IVIM Technology, Inc is 507M KRW (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch IVIM Technology, Inc in the live analysis

One click puts IVIM Technology, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.